COGT
Price
$7.10
Change
-$0.23 (-3.14%)
Updated
Jun 27 closing price
Capitalization
808.95M
44 days until earnings call
NUVL
Price
$79.67
Change
+$0.54 (+0.68%)
Updated
Jun 27 closing price
Capitalization
5.72B
39 days until earnings call
Interact to see
Advertisement

COGT vs NUVL

Header iconCOGT vs NUVL Comparison
Open Charts COGT vs NUVLBanner chart's image
Cogent Biosciences
Price$7.10
Change-$0.23 (-3.14%)
Volume$5.32M
Capitalization808.95M
Nuvalent
Price$79.67
Change+$0.54 (+0.68%)
Volume$2.07M
Capitalization5.72B
COGT vs NUVL Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. NUVL commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and NUVL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (COGT: $7.10 vs. NUVL: $79.67)
Brand notoriety: COGT and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 309% vs. NUVL: 381%
Market capitalization -- COGT: $808.95M vs. NUVL: $5.72B
COGT [@Biotechnology] is valued at $808.95M. NUVL’s [@Biotechnology] market capitalization is $5.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while NUVL’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 6 bearish.
  • NUVL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NUVL is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а -1.80% price change this week, while NUVL (@Biotechnology) price change was +6.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

NUVL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($5.72B) has a higher market cap than COGT($809M). NUVL YTD gains are higher at: 1.776 vs. COGT (-8.974). COGT has higher annual earnings (EBITDA): -284.04M vs. NUVL (-322.59M). NUVL has more cash in the bank: 1.07B vs. COGT (246M). COGT (0) and NUVL (0) have equivalent revenues.
COGTNUVLCOGT / NUVL
Capitalization809M5.72B14%
EBITDA-284.04M-322.59M88%
Gain YTD-8.9741.776-505%
P/E RatioN/AN/A-
Revenue00-
Total Cash246M1.07B23%
Total Debt17.1MN/A-
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTNUVL
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
YCGEX32.360.24
+0.75%
YCG Enhanced
MITGX33.310.19
+0.57%
MFS Massachusetts Investors Tr R1
TEMSX8.880.03
+0.34%
Nuveen Emerging Markets Eq Retiremt
NWGSX28.370.09
+0.32%
Nationwide WCM Focused Sm Cp Instl Svc
RHJSX21.610.05
+0.23%
Rice Hall James Micro Cap Instl

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-3.14%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
+3.59%
IDYA - COGT
55%
Loosely correlated
-4.13%
XNCR - COGT
55%
Loosely correlated
-3.10%
CGON - COGT
53%
Loosely correlated
-0.46%
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+0.68%
CGON - NUVL
56%
Loosely correlated
-0.46%
CRNX - NUVL
50%
Loosely correlated
-0.10%
KYMR - NUVL
50%
Loosely correlated
-3.48%
ROIV - NUVL
50%
Loosely correlated
-1.81%
COGT - NUVL
49%
Loosely correlated
-3.14%
More